Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
2001;52 Suppl 1:21S-34S
MITOL/MARCH5 determines the susceptibility of cardiomyocytes to doxorubicin-induced ferroptosis by regulating GSH homeostasis
COST CONTAINMENT STRATEGIES AND EVOLVING COVERAGES Given the substantial cost of the GLP1 drugs and rising demand, strategies have emerged to contain costs and optimize patient outcomes: Patient identification
These drugs are primarily approved for treating type 2 diabetes, so coverage is usually only available if a patient with PCOS also has type 2 diabetes or obesity as a related condition
Wiesbaden: Otto Harrassowitz Verlag
US$ 25.80
US$ 21.13
US$ 25.12
US$ 25.82
US$ 27.62
US$ 22.63
